Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Diplomat Pharmacy Considers Its Options

TheMotleyFool

0 0

In conjunction with its second-quarter earnings, Diplomat Pharmacy (NYSE: DPLO) disclosed that it's undergoing a review of strategic alternatives that could result in selling all or part of the business. Considering that the second quarter didn't live up to expectations, that may end up as the best option for shareholders.

Metric

Q2 2019

Source Fool.com

Like: 0

DPLO

Share